phentolamine has been researched along with Intellectual Disability in 2 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raikhelkar, J | 1 |
| Anyanwu, A | 1 |
| Gist, RS | 1 |
| Somal, J | 1 |
| Mechanick, JI | 1 |
| Scher, C | 1 |
| Scurlock, C | 1 |
| Carter, CH | 1 |
1 trial available for phentolamine and Intellectual Disability
| Article | Year |
|---|---|
Treatment of upper respiratory tract disorders in children: an evaluation of a new pediatric suspension.
Topics: Acetaminophen; Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Intell | 1965 |
1 other study available for phentolamine and Intellectual Disability
| Article | Year |
|---|---|
Pheochromocytoma presenting as severe biventricular failure requiring insertion of a biventricular assist device.
Topics: Acidosis; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Diabetes Mellitus, Type 1; Diabetic | 2010 |